Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Westphal Christoph H
Relationship:   10% Owner
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   6,222,903    

Indirect Shares

   9,212,891      
Direct Value   $5,789,757    

Indirect Value

   $375,630,484      
Total Shares   15,435,794      
Total Value   $381,420,241      


Verastem, Inc. $2,654,244 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0 Verastem, Inc. $2,654,244 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA Director 2004-06-25 0 2004-06-25 76,648    Premium*  
            Alnylam Pharmaceuticals Inc ALNY Director, 10% Owner 2004-05-27 0 2004-06-03 2,409,970    Premium*  
            Verastem, Inc. VSTM Executive Chairman, Di... 2015-06-30 665,224 2015-06-30 1,500,063    Premium*  
            Tempest Therapeutics, Inc TPST Director, 10% Owner 2014-03-07 701,927 2014-03-07 3,825,421    Premium*  
            Salarius Pharmaceuticals, Inc SLRX 10% Owner 2018-10-16 3,941,118 2018-10-16 0    Premium*  
            Tscan Therapeutics, Inc. TCRX 10% Owner 2021-07-20 914,634 2021-07-20 1,400,789    Premium*  
* Premium Members only  

Records found :    137         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-10 4 B $10.14 $127,531 I/I 12,577 2,990,627 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-11 4 B $10.33 $145,860 I/I 14,120 3,004,747 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-12 4 B $9.94 $160,004 I/I 16,097 3,020,844 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-13 4 B $10.09 $73,344 I/I 7,269 3,028,113 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-16 4 B $10.40 $85,280 I/I 8,200 3,036,313 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-17 4 B $11.14 $202,748 I/I 18,200 3,054,513 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-18 4 B $11.05 $167,960 I/I 15,200 3,069,713 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-19 4 B $11.00 $76,054 I/I 6,914 3,076,627 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-20 4 B $11.44 $11,440 I/I 1,000 3,077,627 2.56 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-23 4 B $12.31 $164,548 I/I 13,367 3,090,994 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-24 4 B $12.50 $212,088 I/I 16,967 3,107,961 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-25 4 B $13.25 $162,975 I/I 12,300 3,120,261 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-26 4 B $12.53 $204,239 I/I 16,300 3,136,561 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-27 4 B $12.68 $219,364 I/I 17,300 3,153,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-31 4 B $12.66 $63,300 I/I 5,000 3,158,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-01 4 B $12.76 $63,800 I/I 5,000 3,163,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-02 4 B $13.22 $66,100 I/I 5,000 3,168,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-03 4 B $12.79 $38,370 I/I 3,000 3,171,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-06 4 B $12.33 $36,990 I/I 3,000 3,174,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-07 4 B $12.26 $36,780 I/I 3,000 3,177,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-08 4 B $12.24 $35,496 I/I 2,900 3,180,761 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-09 4 B $12.04 $36,120 I/I 3,000 3,183,761 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-10 4 B $11.83 $35,490 I/I 3,000 3,186,761 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-13 4 B $11.90 $34,510 I/I 2,900 3,189,661 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-14 4 B $11.19 $33,570 I/I 3,000 3,192,661 2.64 -
  137  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us